The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human study of LY3039478, a Notch signaling inhibitor in advanced or metastatic cancer.
 
Christophe Massard
Honoraria - Amgen; Astellas Pharma; Bayer; Genentech; Ipsen; Lilly; Orion; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Genentech; Lilly; Orion; Sanofi
 
Analia Azaro
No Relationships to Disclose
 
Christophe Le Tourneau
No Relationships to Disclose
 
Jean-Charles Soria
Honoraria - Lilly
Consulting or Advisory Role - Lilly
 
Marie Alt
No Relationships to Disclose
 
Claire Smith
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Ute Ohnmacht
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Gerard Oakeley
Employment - Lilly
Stock and Other Ownership Interests - Cordgenics; Lilly; Nanobiotix
Consulting or Advisory Role - Cordgenics; Nanobiotix
 
Bharvin Patel
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Patents, Royalties, Other Intellectual Property - Lilly
 
Eunice Yuen
Employment - Lilly
Research Funding - Lilly
 
Karim A. Benhadji
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Jordi Rodon Ahnert
Consulting or Advisory Role - Leti Pharma; Lilly; Novartis; Sanofi